Tarsus Pharmaceuticals, Inc. (TARS)
USD 52.7
(-1.05%)
USD 52.7
(-1.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -117.49 Million | -49.03 Million | 3.74 Million | -21.13 Million | -3.67 Million | -1.18 Million |
| Net Income | -135.89 Million | -62.09 Million | -13.82 Million | -26.81 Million | -4.67 Million | -1.31 Million |
| Depreciation & Amortization | 877 Thousand | 325 Thousand | 312 Thousand | 96 Thousand | 37 Thousand | 1000.00 |
| Deferred income taxes | 6.48 Million | - | 1.64 Million | 15 Thousand | 331 Thousand | - |
| Stock-based compensation | 19.83 Million | 13.46 Million | 8.45 Million | 839 Thousand | 18 Thousand | 9000.00 |
| Change in working capital | 306 Thousand | -951 Thousand | 1.37 Million | 1.45 Million | 485 Thousand | 126 Thousand |
| Other non-cash items | -9.1 Million | 227 Thousand | 5.79 Million | 3.26 Million | 126 Thousand | -116 Thousand |
| Investing Cash Flow | 140.6 Million | -144.62 Million | -586 Thousand | -456 Thousand | -175 Thousand | -7000.00 |
| Investments in PPE | -5.5 Million | -506 Thousand | -586 Thousand | -456 Thousand | -175 Thousand | -7000.00 |
| Acquisitions | 4 Million | 144.12 Million | - | - | - | - |
| Investment purchases | -28.66 Million | -149.43 Million | - | - | - | - |
| Sales/Maturities of investments | 174.77 Million | 5.31 Million | - | - | - | - |
| Other Investing Activities | -4 Million | -144.12 Million | - | - | - | - |
| Financing Cash Flow | 130.17 Million | 93.98 Million | 21 Thousand | 131.77 Million | 59.44 Million | 3.56 Million |
| Debt repayment | -10 Million | -19.12 Million | - | - | -1.98 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -28 Thousand | - | - |
| Common Stock Issuance | 120.17 Million | 74.35 Million | 5.49 Million | 91.67 Million | 57.45 Million | 3.56 Million |
| Other Financing Activities | 19.99 Million | 38.76 Million | -5.47 Million | 40.12 Million | 3.97 Million | 3.56 Million |
| Accounts receivables | -14.13 Million | -3.49 Million | -73 Thousand | 16 Thousand | -32 Thousand | -4000.00 |
| Accounts payables | 13.24 Million | 821 Thousand | 3.88 Million | 3.24 Million | 245 Thousand | 131 Thousand |
| Inventory | -3.1 Million | 3.49 Million | 73 Thousand | -16 Thousand | 32 Thousand | - |
| Other working capital | 4.3 Million | -1.77 Million | -2.5 Million | -1.78 Million | 240 Thousand | -5000.00 |
| Cash at beginning of period | 71.66 Million | 171.33 Million | 168.14 Million | 57.97 Million | 2.37 Million | 1000.00 |
| Cash at end of period | 224.94 Million | 71.66 Million | 171.33 Million | 168.14 Million | 57.97 Million | 2.37 Million |
| Capital Expenditure | -5.5 Million | -506 Thousand | -586 Thousand | -456 Thousand | -175 Thousand | -7000.00 |
| Effect of forex changes on cash | 1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | 153.28 Million | -99.67 Million | 3.18 Million | 110.17 Million | 55.59 Million | 2.37 Million |
| Free Cash Flow | -122.99 Million | -49.53 Million | 3.16 Million | -21.59 Million | -3.84 Million | -1.19 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -33.29 Million | -35.73 Million | -41.9 Million | -135.89 Million | -39.14 Million | -31.42 Million |
| Depreciation & Amortization | 239 Thousand | 270 Thousand | 347 Thousand | 877 Thousand | 244 Thousand | 182 Thousand |
| Deferred income taxes | - | - | 1.45 Million | 6.48 Million | -339 Thousand | -1.11 Million |
| Stock-based compensation | 7.48 Million | 5.51 Million | 5.48 Million | 19.83 Million | 5.25 Million | 5.19 Million |
| Change in working capital | 10.25 Million | -8.58 Million | -2.8 Million | 306 Thousand | 1.4 Million | 3.11 Million |
| Other non-cash items | 1.95 Million | 9.04 Million | -1.91 Million | -9.1 Million | 226 Thousand | 226 Thousand |
| Investing Cash Flow | -40.52 Million | -102.22 Million | 17.85 Million | 140.6 Million | 47.36 Million | 64.09 Million |
| Investments in PPE | -1.03 Million | -174 Thousand | 4 Million | -5.5 Million | -4.37 Million | -787 Thousand |
| Acquisitions | - | - | 7.63 Million | 4 Million | 4 Million | - |
| Investment purchases | -47.02 Million | -104.55 Million | - | -28.66 Million | 3000.00 | - |
| Sales/Maturities of investments | 10.54 Million | 2.5 Million | 17.85 Million | 174.77 Million | 51.74 Million | 64.87 Million |
| Other Investing Activities | -3 Million | -102.05 Million | -11.63 Million | -4 Million | -4 Million | 64.87 Million |
| Financing Cash Flow | 42.31 Million | 108.77 Million | 19.76 Million | 130.17 Million | 104.89 Million | 510 Thousand |
| Debt repayment | -71.51 Million | - | -10 Million | -10 Million | -5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -6.68 Million | - | - | - | - | - |
| Common Stock Issuance | 2.68 Million | 108.77 Million | 19.76 Million | 120.17 Million | 99.37 Million | 510 Thousand |
| Other Financing Activities | -31.87 Million | 10.16 Million | 10 Million | 19.99 Million | 10.51 Million | 510 Thousand |
| Accounts receivables | 521 Thousand | -13.64 Million | -11.34 Million | -14.13 Million | -5.36 Million | 2.5 Million |
| Accounts payables | 7.08 Million | 12.33 Million | 8.06 Million | 13.24 Million | 5.81 Million | 409 Thousand |
| Inventory | -692 Thousand | -929 Thousand | -3.09 Million | -3.1 Million | -15 Thousand | - |
| Other working capital | 3.33 Million | -6.34 Million | 3.56 Million | 4.3 Million | 968 Thousand | 206 Thousand |
| Cash at beginning of period | 193.7 Million | 224.94 Million | 226.67 Million | 71.66 Million | 106.77 Million | 65.99 Million |
| Cash at end of period | 181.09 Million | 193.7 Million | 224.94 Million | 224.94 Million | 226.67 Million | 106.77 Million |
| Capital Expenditure | -1.03 Million | -174 Thousand | 4 Million | -5.5 Million | -4.37 Million | -787 Thousand |
| Effect of forex changes on cash | - | - | 119.94 Million | 1.00 | -119.94 Million | - |
| Net cash flow / Change in cash | -12.61 Million | -31.24 Million | -1.72 Million | 153.28 Million | 119.89 Million | 40.77 Million |
| Free Cash Flow | -15.44 Million | -37.96 Million | -35.33 Million | -122.99 Million | -36.73 Million | -24.61 Million |
DBOEY
ZDPY
5257
AMGY
3636
AEC1